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Objective: The primary purpose of the current study was to evaluate the safety and effectiveness of selective coverage of the
left subclavian artery (LSCA) without revascularization during thoracic endovascular aortic repair (TEVAR) in patients
with bilateral patent vertebrobasilar junctions. The secondary purpose was to assess morphologic change of the vertebral
artery (VA) after the procedure.
Methods: Among 126 patients who underwent TEVAR between 2006 and 2011, 29 patients requiring LSCA coverage
without preemptive revascularization were retrospectively analyzed in this study. The patients were a mean age of
63.1 years (range, 45-84 years). The mean follow-up period was 19.9 months (range, 1-63 months). Bilateral patent
vertebrobasilar junctions were evaluated by contrast-enhanced computed tomography (CT), time-of ﬂight magnetic
resonance angiography, or conventional angiography. Neurologic complications, such as spinal cord ischemia (SCI) or
cerebrovascular accidents, were analyzed. Preprocedural and postprocedural changes in VAs were evaluated on follow-up
contrast-enhanced CT.
Results: The overall 30-day mortality was 6.9% (2 of 29). None of the patients had SCI or a stroke of posterior circulation
alone. Cerebrovascular accidents from embolic infarctions occurred in two patients (7.4%). Transient left arm ischemic
symptoms were present in ﬁve patients (18.5%), but none required secondary interventions. Delayed development of type
I endoleak occurred due to stent deformity in one patient, who underwent surgery. One patient required reintervention
after the 10-month follow-up contrast-enhanced CT showed a pseudoaneurysm had developed at the distal margin of the
previously placed stent graft. Hypertrophy of the right VA after TEVAR was seen in seven of 27 patients (25.9%); two
patients showed bilateral hypertrophy of VAs.
Conclusions: LSCA coverage without revascularization can be safely performed during TEVAR in patients with
bilateral patent vertebrobasilar junctions. Hypertrophy of the right VA was noted in 25.9% of patients after LSCA
coverage. (J Vasc Surg 2013;57:1311-6.)Thoracic endovascular aortic repair (TEVAR) has
emerged as a promising therapeutic alternative to conven-
tional open aortic replacement; however, it requires suit-
able proximal and distal landing zones for stent graft
anchoring.1-3 Coverage of the left subclavian artery
(LSCA) during TEVAR is performed in up to 40% of
procedures.4,5 The safety and effectiveness of revasculari-
zation of the LSCA before coverage are still controversial.
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complications, such as spinal cord ischemia (SCI) or
compromised hindbrain circulation and posterior water-
shed infarction. Meanwhile, other studies have revealed
that LSCA coverage without prior transposition or bypass
of the LSCA is generally safe, but the bypass or LSCA
transposition procedures themselves are burdensome in
some patients.6-9
The primary purpose of the current study was to
evaluate the safety and effectiveness of selective coverage
of the LSCA without revascularization during TEVAR in
patients with bilateral patent vertebrobasilar junctions.
Considering few reports have described computed tomog-
raphy (CT) ﬁndings of the vertebral artery (VA) after
coverage of the LSCA, the secondary purpose was to assess
morphologic change of the VA after the procedure.
METHODS
The Institutional Review Board approved the entire
study. Of the 126 patients who underwent TEVAR
between 2006 and 2011 at our institution, 38 with
LSCA coverage were retrospectively enrolled. Nine of1311
Fig 1. Vertebral artery (VA) dominance: I, symmetric; II, left
dominant; III, hypoplasia of the right VA; IV, right dominant; and
V, hypoplasia of the left VA.
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LSCA revascularization before TEVAR.
Preoperative analysis. Bilateral patent vertebrobasilar
junctions in all patients were evaluated by contrast-
enhanced CT, time-of-ﬂight magnetic resonance angiog-
raphy (TOF MRA) or by conventional angiography
when the circle of Willis was not included in the contrast-
enhanced CT.
CT examinations were performed from the vertex to
the level of the common femoral artery with a slice
thickness of 2 mm. VAs were measured by contrast-
enhanced CT at the maximum diameter in the intradural
segment proximal to the anastomosis with the basilar
artery. When contrast-enhanced CT did not include the
circle of Willis, only the foraminal segments of VAs in the
transverse processes were measured. Although there is no
clear deﬁnition of VA hypoplasia, it was deﬁned in this
study as a maximum lumen diameter of <2 mm on
contrast-enhanced CT or TOF MRA. With conventional
angiography, hypoplasia was regarded as a VA thickness
less than half that of the contralateral VA. Patent vertebro-
basilar junctions were categorized into ﬁve types depending
on the dominance and hypoplasia of the VA1: symmetric,
left dominant, right hypoplasia, right dominant, and left
hypoplasia (Fig 1).
Stent graft procedure. Of the 29 patients, 16 (55.2%)
underwent the stent graft procedure with only local
anesthesia, and 13 (44.8%) had intravenous anesthesia as
well as local anesthesia. Bilateral common femoral artery
access was obtained using the preclosure technique with
two Perclose ProGlide devices (Abbott Vascular, Santa
Clara, Calif). Peri-interventional heparin (5000 IU) was
given intravenously. A conduit for access was not required.
Amplatzer vascular plugs (AGA Medical Corp,
Plymouth, Minn) were used to prevent type II endoleaks
in patients with direct LSCA involvement of the aneurysm
or aneurysms with wide necks. SEAL thoracic (S&G
Biotech Inc, Seongnam, Korea; n ¼ 17) or Valiant Captivia
(Medtronic, Minneapolis, Minn; n ¼ 12) stent grafts with
diameters of 26 to 46 mm and lengths of 80 to 219 mm
were implanted.
Blood pressure was not brought down during
deployment of the stent graft. In the event a type I endo-
leak occurred, a large, compliant, low-pressure Coda
balloon (Cook Inc, Bloomington, Ind) inﬂated with
a hand-held syringe was used in patients with an aortic
aneurysm, but not in patients with dissection after the
blood pressure was brought down using nitroprusside or
right ventricular pacing. When the stent graft coverage of
the descending thoracic aorta was >20 cm in length,
cerebrospinal ﬂuid drainage was performed before TEVAR.
Complications and follow-up assessment. Data on
neurologic complications, such as SCI or cerebrovascular
accidents (CVA), and non-neurologic complications
after TEVAR were gathered from medical records. To
be included in our analysis, CVA and SCI had to be
newly diagnosed by a neurologist with symptoms lasting
>72 hours. Contrast-enhanced CT was obtained #1month after the procedure and annually thereafter if there
were no remarkable abnormalities, such as immediate
migration or endoleak, that would require repeat inter-
vention or closer observation. If contrast-enhanced CT
revealed type I or II endoleak without other associated
abnormalities at the 1-month follow-up, 3- and 6-month
follow-up CT examinations were performed.
Preprocedural and postprocedural changes in VA
maximum diameter were evaluated at the intradural or
foraminal segments on follow-up contrast-enhanced CT.
VA hypertrophy was deﬁned as a VA of at least 1 mm larger
than it was before the procedure.RESULTS
Patient demographics and comorbidities are listed in
Table I. The study enrolled 29 of 38 patients with LSCA
coverage without preemptive revascularization. Among
nine patients excluded, six underwent revascularization of
LSCA due to a previous coronary bypass graft from the
left internal mammary artery. Of the remaining three
patients (9.4%), two demonstrated no communications
between the left and the right VA and one patient had
multifocal atherosclerotic calciﬁcations with stenosis in
the intradural segment and the origin of the right VA,
resulting in LSCA bypass surgery.
Among the 29 patients (19 men, 10 women; mean age,
63.1; range, 45-84 years), 19 received stent grafts for
thoracic aortic aneurysm and 10 for aortic dissection.
The mean follow-up period was 19.9 months (range, 1-63
months). Emergency procedures were performed in two
patients (6.9%), of which one had traumatic aortic rupture
and the other had aortic dissection with dynamic obstruc-
tion of abdominal branch vessel. The remaining 27 cases
were elective (93.1%). The 10 dissection cases were chronic.
Bilateral patent vertebrobasilar junctions were conﬁrmed
by conventional angiography in 14, contrast-enhanced
CT in 13, or TOF MRA in two. Patent vertebrobasilar
junctions were categorized as symmetric VAs (n ¼ 12),
Table I. Patient demographics (N ¼ 29)
Variable Median 6 SD or No. (%)
Age, years 63.1 6 14.6
Sex
Men 19 (65.5)
Women 10 (34.5)
Emergency 2 (6.9)
Elective 27 (93.1)
Traumatic 2 (6.9)
Nontraumatic 27 (93.1)
Comorbidities
Hypertension 24 (82.8)
Diabetes 3 (10.3)
Coronary artery disease 5 (17.2)
Stroke 4 (13.8)
End-stage renal disease 2 (6.9)
Peripheral vascular disease 1 (3.4)
Previous aortic operation 2 (6.9)
Abdominal aortic aneurysm 1 (3.4)
SD, Standard deviation.
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hypoplasia (n ¼ 2), or right VA hypoplasia (n ¼ 2).
There were no technical failures of stent graft
placement during TEVAR. Vascular plugs for occlusion
of the LSCA were used in 15 patients, and LSCA coverage
with the stent graft alone was performed in the remaining
14. Four of 29 patients (13.8%) underwent cerebrospinal
ﬂuid drainage before TEVAR. Two patients underwent
carotid-to-carotid bypass surgery to ensure suitable prox-
imal landing zones. One patient underwent simultaneous
abdominal and thoracic aortic aneurysm treatment with
a stent graft and was successfully treated without neuro-
logic complications.
Complications. The overall 30-day mortality was 6.9%
(2 of 29). One patient died of recurrent massive hemop-
tysis due to chronic destructive lung disease. The other
patient was treated emergently due to traumatic aortic
rupture but died of multiorgan failure 7 days after stent
graft placement. No deaths or complications were related
to aneurysm rupture.
None of the patients had SCI or stroke of the posterior
circulation alone. CVA occurred in two patients (7.4%).
The ﬁrst patient was a 69-year-old man who experienced
right-sided weakness and dysarthria after the procedure.
Magnetic resonance imaging (MRI) revealed multifocal
infarctions in the pons, cerebellum, right temporal occipital
lobe, and the left parietal lobe. The second patient was
a 51-year-old man who developed a medial gaze palsy after
the procedure. MRI demonstrated focal infarctions in the
right frontal lobe and the left cerebellum. The medial
gaze palsy completely resolved after 1 month. Both patients
had symmetric VAs.
Left arm symptoms were noted in ﬁve patients (18.5%),
including arm claudication (n ¼ 3), tingling sensation upon
elevation of the left arm (n ¼ 2), and pain (n ¼ 1), all of
which were tolerable at rest, spontaneously resolved at
median of 5 months (range, 1-12 months), and none of
which required secondary interventions.A postimplantation syndrome, including fever, was
noted in seven patients (25.9%), and they were subse-
quently managed with conservative treatment. A hema-
toma at the puncture site was noted in one patient (3.7%).
Follow-up contrast-enhanced CT. Type I endoleaks
after stent graft placement were noted in ﬁve patients
(18.5%), including one with delayed development at 4.5
years due to stent deformity. Four of these patients experi-
enced spontaneous resolution at a median follow-up of 5
months (range, 1-12 months). In one patient, we initially
found no endoleak after the procedure, but delayed
development of a type I endoleak occurred due to stent
deformity with increasing aneurysmal sac size, and the
patient subsequently underwent open surgery without
LSCA revascularization. One patient required reinterven-
tion after the 10-month follow-up contrast-enhanced CT
showed pseudoaneurysm had developed at the distal
margin of the previously placed stent graft on the
descending thoracic aorta. A type II endoleak from the
LSCA was encountered in one patient (3.4%) who under-
went LSCA coverage without a plug, which closed
spontaneously.
Change of the VA on follow-up CT scan. Serial
changes of the hypertrophied right VA diameter after
TEVAR are summarized in Table II. Seven of 27 patients
(25.9%) presented with hypertrophy of the right VAs after
TEVAR, including four of 15 instances (26.6%) at the
foraminal segment and three of 12 (25%) at the intradural
segment (Fig 2). Two patients had bilateral VA hyper-
trophy. Mean diameter of VAs in patients with hypertrophy
changed from 3.5 6 0.9 to 4.7 6 0.9 mm after the
procedure. VAs were increased as fast as 1 month after
TEVAR and grew up to 36 months. Aortographies
revealed reversal of left VA ﬂows immediately after TEVAR
in all patients, with or without embolization of the LSCA
using a plug.
DISCUSSION
The endovascular repair of thoracic aortic pathologies
offers a minimally invasive alternative to open repair and
is increasingly replacing the traditional open surgical repair
of diseases of the descending thoracic aorta.1,2 TEVAR can
be complicated by the requirement of suitable proximal
and distal landing zones for stable stent graft ﬁxation. It
has been suggested that 2 cm of normal aortic wall are
required for an adequate and stable seal10,11; however,
many aortic pathologies affect the area near the LSCA,
limiting the proximal landing zone site without proximal
vessel coverage. It has been reported that about 40% of
LSCAs should be covered during TEVAR.4,5
There is controversy regarding the safety of LSCA
coverage without revascularization before TEVAR because
the process may alter the circulation of the vertebrobasilar
system and upper extremity. A multicenter registry analysis
by Buth et al12 suggested that the incidence of paraplegia
due to SCI and stroke was higher in patients requiring
LSCA coverage (8.4%) than in patients who received
prophylactic revascularization (0%). Other studies have
Table II. Serial changes of the hypertrophied right VA
diameter after TEVAR
Segment Pt
VA diameter, mm
Initial
At follow-up month
1 3 6 12 24 36
Foraminal (n ¼ 4/15) 2 3.2 4 4.1 4.2 4.2 4.2 4.2
4 3.8 4.2 . . 4.8 . .
13 3.8 4.3 . . 4.3 5.2 5.3
17 4.8 5.2 . . 5.2 5.5 5.8
Intradural (n ¼ 3/12) 8 4.6 5.5 . . 6.1 . .
11 1.7 . 3 3 3 . .
23 2.6 3.6 . . 4 . .
TEVAR, Thoracic endovascular aortic repair; VA, vertebral artery.
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covered without preceding or simultaneous revasculariza-
tion.13,14 A study by Tiesenhausen et al,9 however,
revealed no signs of malperfusion after LSCA coverage
without revascularization. They noted that surgical treat-
ments performed with bypass or LSCA transposition corre-
lated with a mortality of 1.2% to 5%, thereby increasing the
overall risk of TEVAR. Furthermore, whether routine
revascularization results in a reduction in perioperative
stroke complications is not clear.
Reported complication rates are inconsistent due to
sample size limitations and heterogeneity in patient selec-
tion criteria. A 2009 consensus statement from the Society
of Vascular Surgery described the “very low” quality of
existing evidence regarding performance of LSCA revascu-
larization in patients undergoing TEVAR.15 According to
a meta-analysis, revascularization of LSCA demonstrated
no protective effect for CVA and had only a questionable
protective role for SCI.16 Owing to the lack of evidence
about the potential role of LSCA revascularization, conser-
vative patient selection is used to avoid unnecessary opera-
tions. Some authors propose prophylactic revascularization
only in select cases of an aberrant right subclavian artery,
previous myocardial revascularization with the left internal
mammary artery, critically stenosed carotid or VA,
occluded contralateral VA, functional compromise of the
circle of Willis, an arteriovenous shunt for hemodialysis in
the left arm, and in left-handed patients.17,18
Criado et al10 described the general safety of LSCA
coverage without revascularization, even without prior
transposition or bypass; however, they recommended
ascertaining the angiographic patency of the contralateral
VA beforehand. Preoperative contrast-enhanced CT,
MRI, or angiography may be helpful in selecting candi-
dates for adjunct LSCA revascularization.11
We also evaluated VA anatomy in our study, speciﬁcally
focusing on the communication between both VAs as they
join to form the basilar artery. Currently, our contrast-
enhanced CT protocols for aortic pathology cover the
entire area, from the whole brain to the common femoral
arteries, with a 2-mm slice thickness. This detail makes itunnecessary to do conventional angiography and enables
us to quickly determine whether LSCA coverage without
revascularization can be safely performed. In addition, we
suggest that our study’s ﬁndings are more applicable for
patients with traumatic aortic pathology who require an
emergency decision of stent graft placement because these
patients often undergo LSCA coverage without revascular-
ization, even with little information about their VA
anatomy.
Our study enrolled 29 of 38 patients and excluded nine
patients. Six underwent a previous coronary artery bypass
graft from the left internal mammary artery, so we did
not need to evaluate vertebral communications. Three
of 32 patients (9.4%) needed bypass surgery of the
LSCA; of these, two did not have patent vertebrobasilar
junctions, and one had multifocal atherosclerotic calciﬁca-
tions with stenosis in the intradural segment and the origin
of the right VA, with patent communication between the
left and right VAs. Without a doubt, we believe that the
entire right VA, as well as the vertebrobasilar junctions,
should be patent in instances of LSCA coverage without
revascularization.
Theoretically, the posterior communicating arteries
may play a role in collateral supply as well when the left
VA is occluded. In this study, however, we investigated
vertebrobasilar junctions on axial images, on which the
VAs were well visualized and patency was easier to evaluate,
compared with the posterior communicating arteries. In
addition, the VA is generally larger than the posterior
communication artery and could contain more collateral
supply than the posterior communication artery when the
left VA is occluded.
We did not perform duplex ultrasound imaging to
document the directionality of VA ﬂow. However, all
patients underwent aortographies immediately after
TEVAR, which revealed reversal of left VA ﬂows. Two
patients in our study had stroke events after TEVAR,
and MRI revealed multifocal infarcts in the anterior and
posterior circulation territory. These strokes were likely
due to atheroembolization from the aortic arch because
the risk of embolic stroke during thoracic aortic stent
graft placement is inherent due to manipulation of wires,
catheters, and devices in the aortic arch. However, we
would like to acknowledge that in multifocal infarctions
in the anterior and posterior circulation, lesions in the
posterior circulation might be related with simultaneous
ischemia with embolic infarcts in anterior circulation.
Covering the LSCA can lead to type II endoleaks due
to retrograde perfusion from the LSCA into the aneurysm
sac or the false lumen of the dissection. This potential
complication is a commonly cited justiﬁcation for LSCA
revascularization. We use vascular plugs to prevent type
II endoleaks in patients with direct LSCA involvement of
the aneurysm or aneurysms with wide necks. Only one of
14 patients in this study who underwent LSCA coverage
without a plug presented with a type II endoleak, which
resolved spontaneously. None of the patients treated with
vascular plugs for LSCA coverage had type II endoleaks.
Fig 2. Images are shown for a 73-year-old man with a traumatic aortic pseudoaneurysm. A, A contrast-enhanced
computed tomography (CT) scan reveals an aortic pseudoaneurysm (arrows) at the proximal descending thoracic
aorta. B, A patent vertebrobasilar junction (dotted arrow) is demonstrated. The left vertebral artery (VA) (thick arrow)
is dominant compared with the hypoplastic right VA (thin arrow). C, The left subclavian artery (LSCA) is covered,
without recanalization, during the stent graft procedure. D, A contrast-enhanced CT scan at the 6-month follow-up
reveals the right VA (thin arrow) hypertrophy that is nearly the same as the left VA (thick arrow).
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 5 Lee et al 1315Further studies are needed to determine whether vascular
plugs may play a role in preventing type II endoleaks
from the LSCA in such patients.
A dominant left VA is typically an indication for revas-
cularization before LSCA coverage during TEVAR5,15,16;
however, it has recently been suggested that a dominant
left VA alone, without other indications, does not require
revascularization.19 We performed LSCA coverage without
revascularization in nine patients who had left dominant
VAs or hypoplasia of right VAs, and none exhibited SCI
or CVA on posterior circulation alone. Although the
small study population limits the drawing of a deﬁnitive
conclusion, there appear to be few serious complications
directly related to LSCA coverage without revasculariza-
tion, even in patients with a left dominant VA, if bilateral
vertebrobasilar junctions are patent.In addition, stent graft placement for abdominal aortic
aneurysm is also known as a risk factor of paraplegia during
TEVAR with LSCA coverage, but a case in our study
implicated that TEVAR with LSCA coverage without
revascularization might be carefully performed even in
patients treated for AAA if bilateral vertebrobasilar
junctions are patent; but, larger studies are needed.
Interestingly, seven of 27 patients (25.9%) in our study
demonstrated hypertrophy of the right VA. VAs increased
in size as fast as 1 month later after TEVAR and grew up to
36 months. Two of these had bilateral hypertrophy of
the VAs on the follow-up CT scan. Two patients had hypo-
plastic right VAs before treatment, but after TEVAR, the
right VAs became larger than the left VAs. These ﬁndings
may result from right VA compensation for reduced LSCA
blood ﬂow. To our knowledge, few other reports have
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on CT scan.
The incidence of left arm ischemia is reported between
0% and 36%.20 Overall, left upper extremity symptoms
occur in w20% of patients who undergo TEVAR and
LSCA coverage without prior revascularization. Five of
27 patients (18.5%) in our study had left arm symptoms,
but no patients required a secondary intervention.
The present study has a few limitations. The retrospec-
tive study design, without comparing a nonrevascularized
group with revascularized group, may have yielded biased
results. As a second limitation, preprocedural and post-
procedural VA diameters of intradural segments were
not compared in all patients. Some patients enrolled in
our study underwent preprocedural CT imaging that did
not cover the level of the circle of Willis, and their VA
diameters were compared among only foraminal segments
after TEVAR on follow-up CT scan, even though a similar
rate of VA hypertrophy was demonstrated with foraminal
segments as intradural segments. Another limitation is
the relatively small number of patients; further large, multi-
center studies are needed.
CONCLUSIONS
LSCA coverage without revascularization can be safely
performed during TEVAR in patients with bilateral patent
vertebrobasilar junctions. Hypertrophy of the right VA was
noted in 25.9% of patients after LSCA coverage.
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